Genetic polymorphism of CYP2D6 in a Keralite (South India) population

被引：0
作者：
Abraham, BK [1 ]
Adithan, C
Shashindran, CH
Vasu, S
Alekutty, NA
机构：
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Pharmacol, Pondicherry 605006, India
[2] Mahatma Gandhi Univ, Dept Pharmaceut Sci, Kottayam, Kerala, India
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：285 / 286
页数：2
相关论文
共 50 条
[41]   CYP2D6 genetic polymorphism and psychiatry patients' hospitalization period [J].
Penas-LLedo, Eva M. ;
LLerena, Adrian .
BIOMARKERS IN MEDICINE, 2013, 7 (06) :915-916
[42]   CYP2D6 genetic polymorphism and extrapyramidal effects of antipsychotic drugs [J].
Plesnicar, BK ;
Dolzan, V ;
Zalar, B ;
Tomori, M ;
Breskvar, K .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S266-S266
[43]   CYP2D6 polymorphism in Chinese breast cancer population. [J].
Li, Kai ;
Liao, Ning .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[44]   Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis [J].
Małgorzata Barańska ;
Bożena Dziankowska-Bartkowiak ;
Elżbieta Waszczykowska ;
Mariola Rychlik-Sych ;
Jadwiga Skrętkowicz .
Pharmacological Reports, 2012, 64 (2) :336-342
[45]   Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations [J].
S. Wanwimolruk ;
S. Bhawan ;
P. F. Coville ;
S. C. W. Chalcroft .
European Journal of Clinical Pharmacology, 1998, 54 :431-435
[46]   Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations [J].
Wanwimolruk, S ;
Bhawan, S ;
Coville, PF ;
Chalcroft, SCW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (05) :431-435
[47]   Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan [J].
Abduljalil, K. ;
Frank, D. ;
Gaedigk, A. ;
Klaassen, T. ;
Tomalik-Scharte, D. ;
Jetter, A. ;
Jaehde, U. ;
Kirchheiner, J. ;
Fuhr, U. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) :643-651
[48]   Serotonin syndrome - "potential" role of the CYP2D6 genetic polymorphism in Asians [J].
Kaneda, Y ;
Kawamura, I ;
Fujii, A ;
Ohmori, T .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2002, 5 (01) :105-106
[49]   Genetic polimorphism of CYP2C9 and CYP2D6 in the Croatian population [J].
Bozina, N ;
Tramisak, I ;
Granic, P ;
Stavljenic-Rukavina, A .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 :187-187
[50]   Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine [J].
Ji-Yeong Byeon ;
Choong-Min Lee ;
Yea-Jin Lee ;
Young-Hoon Kim ;
Se-Hyung Kim ;
Eui Hyun Jung ;
Won Ki Chae ;
Yun Jeong Lee ;
Choon-Gon Jang ;
Seok-Yong Lee .
Archives of Pharmacal Research, 2019, 42 :182-190
12345